The region of interest can be assesses both automatically and through experts. This strategy helps so much in saving the time and efforts of specialists with the explosion of COVID-19 pandemic in the world. The proposed classification approach is applied for different scenarios of 80%, 70%, or 60% of the data for training and 20%, 30, or 40% of the data for testing, respectively. In these scenarios, the proposed approach achieves classification accuracies of 100%, 99.45%, and 98.55%, respectively. Thus, the obtained results demonstrate and prove the efficacy of the proposed approach for assisting the specialists in automated medical diagnosis services.
Automated diagnosis based on medical images is a very promising trend in modern healthcare services. For the task of automated diagnosis, there should be flexibility to deal with an enormous amount of data represented in the form of medical images. In addition, efficient algorithms that could be adapted according to the nature of images should be used. The importance of automated medical diagnosis has been maximized with the evolution of COVID-19 pandemic. COVID-19 first appeared in China, Wuhan, and then it has exploded in the whole world with a very bad impact on our daily life. The third wave of COVID-19 in the third world is really a disaster in current days, especially with the emergence of the delta variant of COVID-19 that is widespread. Required inspections should be carried out to monitor the COVID-19 spread in daily life and allow primary diagnosis of suspected cases, and long-term clinical laboratory monitoring. Healthcare professionals or radiologists can exploit AI (Artificial Intelligence) tools to quickly and reliably identify the cases of COVID-19. This paper introduces a DCNN (Deep Convolutional Neural Network) framework for chest X-ray and CT image classification based on TL (Transfer Learning). The objective is to perform multi-class and binary classification of the images in order to determine pneumonia and COVID-19 case. The TL is feasible, when using a small dataset by transferring knowledge from natural image classification to medical image classification. Two types of TL are used. The first type is finetuning of the DenseNet121, Densenet169, DenseNet201, ResNet50, ResNet152, VGG16, and VGG19 models. The second type is deep tuning of the LeNet-5, AlexNet, Inception naïve v1, and VGG16 models. Extensive tests have been carried out on datasets of chest X-ray and CT images with different training/testing ratios of 80%:20%, 70%:30%, and 60%:40%. Experimental results on 9,270 chest X-ray ray and 2,762 chest CT images acquired from different institutions show that the TL is effective with an average accuracy of 98.49%.
infection was initially acknowledged as a global pandemic in Wuhan in China. World Health Organization (WHO) stated that the COVID-19 is an epidemic that causes a 3.4% death rate. Chest X-Ray (CXR) and Computerized Tomography (CT) screening of infected persons are essential in diagnosis applications. There are numerous ways to identify positive COVID-19 cases. One of the fundamental ways is radiology imaging through CXR, or CT images. The comparison of CT and CXR scans revealed that CT scans are more effective in the diagnosis process due to their high quality. Hence, automated classification techniques are required to facilitate the diagnosis process. Deep Learning (DL) is an effective tool that can be utilized for detection and classification this type of medical images. The deep Convolutional Neural Networks (CNNs) can learn and extract essential features from different medical image datasets. In this paper, a CNN architecture for automated COVID-19 detection from CXR and CT images is offered. Three activation functions as well as three optimizers are tested and compared for this task. The proposed architecture is built from scratch and the COVID-19 image datasets are directly fed to train it. The performance is tested and investigated on the CT and CXR datasets. Three activation functions: Tanh, Sigmoid, and ReLU are compared using a constant learning rate and different batch sizes. Different optimizers are studied with different batch sizes and a constant learning rate. Finally, a comparison between different combinations of activation functions and optimizers is presented, and the optimal configuration is determined. Hence, the main objective is to improve the detection accuracy of COVID-19 from CXR and CT images using DL by employing CNNs to classify medical COVID-19 images in an early stage. The proposed model achieves a classification accuracy of 91.67% on CXR image dataset, and a classification accuracy of 100% on CT dataset with training times of 58 min and 46 min on CXR and CT datasets, respectively. The best
The early discovery of the disease is a great achievement in management of the cornea. This paper presents an efficient approach for the classification of normal and abnormal corneal patterns based on deep learning. Convolutional Neural Networks (CNNs) are utilized for this purpose. The CNN model built for this purpose comprises5 layers. The classification process is achieved through two stages. Automatic feature extraction based CNN is applied in the first stage, followed by sequence of processing layers includes: pooling layer, dropout layer and fully connected layer resulted in a diagnosis of the condition of the patient in terms of normal or abnormal. The proposed technique was tested and evaluated based MATLAB environment on a set of corneal images. These images were collected for patients based on confocal microscopy. The CNN classification results on corneal fundus images recorded an accuracy of 100 %.
R Re ed da a a am mm ma ar r D De ep pt t.. o of f E El le ec ct tr ro on ni ic cs s a an nd d E El le ec ct tr ri ic ca al l C Co om mm mu un ni ic ca at ti io on ns s E En ng gi in ne ee er ri in ng g. ., , F Fa ac cu ul lt ty y o of f E El le ec ct t.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.